These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32603251)

  • 1. Opioid Risk Screening in an Oncology Palliative Medicine Clinic.
    Greiner RS; Boselli D; Patel JN; Salib M; Edelen C; Walsh D
    JCO Oncol Pract; 2020 Nov; 16(11):e1332-e1342. PubMed ID: 32603251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF.
    Koyyalagunta D; Bruera E; Aigner C; Nusrat H; Driver L; Novy D
    Pain Med; 2013 May; 14(5):667-75. PubMed ID: 23631401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center.
    Yennurajalingam S; Edwards T; Arthur JA; Lu Z; Najera J; Nguyen K; Manju J; Kuriakose L; Wu J; Liu D; Williams JL; Reddy SK; Bruera E
    Cancer; 2018 Oct; 124(19):3942-3949. PubMed ID: 30192372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
    Varney SM; Perez CA; Araña AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
    Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of an Eight-Item Brief Form of the SOAPP-R (SOAPP-8).
    Black RA; McCaffrey SA; Villapiano AJ; Jamison RN; Butler SF
    Pain Med; 2018 Oct; 19(10):1982-1987. PubMed ID: 29024987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).
    Butler SF; Fernandez K; Benoit C; Budman SH; Jamison RN
    J Pain; 2008 Apr; 9(4):360-72. PubMed ID: 18203666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the screener and opioid assessment for patients with pain-revised (SOAPP-R) in patients with cancer.
    Yasin JT; Leader AE; Petok A; Garber G; Stephens B; Worster B
    J Opioid Manag; 2019; 15(4):272-274. PubMed ID: 31637679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
    Chou R; Fanciullo GJ; Fine PG; Miaskowski C; Passik SD; Portenoy RK
    J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients.
    Bruehl S; Burns JW; Passik SD; Gupta R; Buvanendran A; Chont M; Schuster E; Orlowska D; France CR
    J Pain; 2015 Jul; 16(7):666-75. PubMed ID: 25892658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain.
    Yennurajalingam S; Arthur J; Reddy S; Edwards T; Lu Z; Rozman de Moraes A; Wilson SM; Erdogan E; Joy MP; Ethridge SD; Kuriakose L; Malik JS; Najera JM; Rashid S; Qian Y; Kubiak MJ; Nguyen K; PharmD ; Wu J; Hui D; Bruera E
    JAMA Oncol; 2021 Mar; 7(3):404-411. PubMed ID: 33410866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study for Customized Computer-Based Testing.
    Finkelman MD; Kulich RJ; Zacharoff KL; Smits N; Magnuson BE; Dong J; Butler SF
    Pain Med; 2015 Dec; 16(12):2344-56. PubMed ID: 26176496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Short-Form Versions of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study.
    Finkelman MD; Smits N; Kulich RJ; Zacharoff KL; Magnuson BE; Chang H; Dong J; Butler SF
    Pain Med; 2017 Jul; 18(7):1292-1302. PubMed ID: 27605589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Pain and Risk Factors for Opioid Misuse in a Palliative Care Clinic.
    Childers JW; King LA; Arnold RM
    Am J Hosp Palliat Care; 2015 Sep; 32(6):654-9. PubMed ID: 24744398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department.
    Weiner SG; Horton LC; Green TC; Butler SF
    Drug Alcohol Depend; 2016 Feb; 159():152-7. PubMed ID: 26743334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP).
    Akbik H; Butler SF; Budman SH; Fernandez K; Katz NP; Jamison RN
    J Pain Symptom Manage; 2006 Sep; 32(3):287-93. PubMed ID: 16939853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain.
    Koyyalagunta D; Bruera E; Engle MP; Driver L; Dong W; Demaree C; Novy DM
    Pain Med; 2018 Jul; 19(7):1469-1477. PubMed ID: 29016951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish translation and linguistic validation of the screener and opioid assessment for patients with pain-revised (SOAPP-R).
    Butler SF; Zacharoff KL; Budman SH; Jamison RN; Black R; Dawsey R; Ondarza A
    Pain Med; 2013 Jul; 14(7):1032-8. PubMed ID: 23590454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a screener and opioid assessment measure for patients with chronic pain.
    Butler SF; Budman SH; Fernandez K; Jamison RN
    Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R).
    Butler SF; Budman SH; Fernandez KC; Fanciullo GJ; Jamison RN
    J Addict Med; 2009 Jun; 3(2):66-73. PubMed ID: 20161199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
    Passik SD; Narayana A; Yang R
    Pain Med; 2014 Aug; 15(8):1365-72. PubMed ID: 24666664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.